-
From revelations in treatment options to the likelihood of inheriting type 1 diabetes, the presentations at EASD 2024 will potentially shape the future of diabetes management and prevention.
-
Studies presented at ADA showcase new treatment options for type 2 diabetes and weight management for obesity.
-
Research presented highlights the benefits of CGM metrics in predicting the progression and risk of the condition.
Nerve disease is one of the most common diabetes-related complications, occurring in approximately 1 in 2 people living with the condition.
> Read more
The IDF SEA region includes seven countries and territories, each with unique socioeconomic and healthcare challenges. However, one common thread is the rising diabetes impact.
> Read more
In a disaster situation, organisations and individuals can appeal to international laws and conventions and relevant UN bodies like the WHO to demand accountability and ensure access to diabetes care and supplies.
> Read more
The resurgence of mpox in African countries has led the World Health Organization (WHO) to declare a “public health emergency of international concern”.
> Read more
With approximately 24 million adults affected and significant disparities in care, Africa is set to register the highest increase in the number of people with diabetes of all regions by 2045.
> Read more